Traditional Three Incisions vs Minimally Invasive Thoracol-laparoscopic Esophagectomy for Esophageal Cancer

NCT02355249 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 648

Last updated 2015-02-04

No results posted yet for this study

Summary

This study is a multi-center, randomized, and open-label trial to compare the safety and feasibility of traditional three incisions and minimally invasive thoracol-laparoscopic esophagectomy for esophageal cancer.

Conditions

  • Esophageal Carcinoma

Interventions

PROCEDURE

MIE

Minimally invasive thoracol-laparoscopic esophagectomy will be performed in this group.

PROCEDURE

OE

Patients will be treated with traditional three incisions esophagectomy.

Sponsors & Collaborators

  • China-Japan Friendship Hospital

    collaborator OTHER
  • Peking University Cancer Hospital & Institute

    collaborator OTHER
  • Beijing Chao Yang Hospital

    collaborator OTHER
  • Peking University Third Hospital

    collaborator OTHER
  • The Second People's Hospital of Sichuan

    collaborator OTHER
  • First Affiliated Hospital of Chongqing Medical University

    collaborator OTHER
  • Hunan Cancer Hospital

    collaborator OTHER
  • The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China

    collaborator OTHER
  • First Hospital of China Medical University

    collaborator OTHER
  • Quanzhou First Hospital

    collaborator OTHER
  • Jiangxi Provincial People's Hopital

    collaborator OTHER
  • People's Hospital of Guangxi Zhuang Autonomous Region

    collaborator OTHER
  • Chinese Academy of Medical Sciences

    lead OTHER

Principal Investigators

  • Jie He, MD · Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2017-12-31
Completion
2018-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02355249 on ClinicalTrials.gov